USMV vs XBI
iShares MSCI USA Min Vol Factor ETF vs SPDR S&P Biotech ETF
- • USMV has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • USMV pays a higher dividend yield (1.37%).
Side-by-side metrics
| Metric | USMV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.37% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $24.03B | $10.92B |
YTD return | 10.50% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.45 | 1.01 |
P/E ratio | 22.32 | — |
Last price | $103.96 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
USMV top holdings
| XOM | ExxonMobil Holdings Corp | 1.61% |
| MSFT | Microsoft Corp | 1.59% |
| CB | Chubb Ltd | 1.54% |
| MSI | Motorola Solutions Inc | 1.50% |
| BRK-B | Berkshire Hathaway Inc Class B | 1.50% |
| APH | Amphenol Corp Class A | 1.50% |
| MCK | McKesson Corp | 1.47% |
| JNJ | Johnson & Johnson | 1.47% |
| WELL | Welltower Inc | 1.46% |
| MRK | Merck & Co Inc | 1.45% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About USMV
USMV (iShares MSCI USA Min Vol Factor ETF) is US stocks selected for lower volatility. Managed by iShares, the fund carries $24.0B in assets under management, an expense ratio of 0.15%, a dividend yield of 1.37%. Its largest holding is ExxonMobil Holdings Corp (XOM), which represents 1.6% of the portfolio. Real Estate is the fund's largest sector exposure at 2.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.